...
首页> 外文期刊>The Journal of Veterinary Medical Science >DNA Sequence Analysis of Glycoprotein G Gene of Bovine Ephemeral Fever Virus and Development of a Double Oil Emulsion Vaccine against Bovine Ephemeral Fever
【24h】

DNA Sequence Analysis of Glycoprotein G Gene of Bovine Ephemeral Fever Virus and Development of a Double Oil Emulsion Vaccine against Bovine Ephemeral Fever

机译:牛短暂性发热病毒糖蛋白G基因的DNA序列分析和抗牛短暂性发热的双油乳剂疫苗的研制

获取原文
   

获取外文期刊封面封底 >>

       

摘要

References(26) Cited-By(7) The surface glycoprotein G is considered as the major neutralizing and protective antigen of bovine ephemeral fever virus (BEFV). Comparison of the deduced amino acid sequence of G protein of BEFV isolates during the period 1984-2004 outbreaks in Taiwan showed amino acid substitutions in the neutralizing epitopes. All the isolates differ markedly in the neutralizing epitope at the same amino acid positions compared to the currently available killed vaccine strain (Tn73). Tn88128 strain isolated in 1999 showed the maximum variability of 12 amino acids, 5 amino acid in the neutralization epitope and 7 apart from, respectively. Combinations of both Tn88128 (1999) and commercially available vaccine strain (Tn73) were developed and its safety was evaluated in mice, guinea pigs, calves, and pregnant cows. None of the animals showed any adverse effect or clinical signs. Calves were immunized with commercial vaccine (Tn73) and, combined vaccine (Tn73 and Tn88128), respectively, with adjuvants such as Al-gel and water-in-oil-in-water (w/o/w) oil and PBS alone and challenged with Tn88128 strains. Except PBS administered animals, all the vaccinated animals showed protective immune response. However, animals immunized with combined vaccine plus w/o/w adjuvant elicited stronger neutralization antibodies and long lasting immunity compared to other vaccines.
机译:参考文献(26)被引用的By(7)表面糖蛋白G被认为是牛短暂性发热病毒(BEFV)的主要中和和保护性抗原。比较台湾1984-2004年暴发期间BEFV分离株G蛋白的推导氨基酸序列,结果显示中和表位中存在氨基酸取代。与目前可用的灭活疫苗株(Tn73)相比,所有分离物在相同氨基酸位置的中和表位明显不同。 1999年分离的Tn88128菌株显示出最大的变异性,分别是12个氨基酸,中和表位的5个氨基酸和7个氨基酸的最大变异。开发了Tn88128(1999)和市售疫苗株(Tn73)的组合,并在小鼠,豚鼠,犊牛和怀孕的母牛中评估了其安全性。没有动物显示出任何不良反应或临床症状。用商业疫苗(Tn73)和联合疫苗(Tn73和Tn88128)分别用佐剂如Al-gel和水包油包水(w / o / w)油以及单独的PBS免疫小牛。用Tn88128菌株挑战。除施用PBS的动物外,所有接种的动物均显示保护性免疫应答。但是,与其他疫苗相比,用联合疫苗加w / o / w佐剂免疫的动物引起更强的中和抗体和持久的免疫力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号